Metabolic & endocrine
Retatrutide
Triple GIP, GLP-1 and glucagon receptor agonist
Price per bottle · Shipping charged separately.
COMPOUND OVERVIEW
What's In It
Retatrutide (LY3437943 sequence)
A synthetic 39-amino-acid triple-agonist peptide engineered to bind GIP, GLP-1, and glucagon receptors, supplied strictly as an unapproved investigational laboratory reference material. Not a medicine and not for human or veterinary use.
Areas of Research Interest
- GLP-1/GIP/glucagon receptor research
- GLP-1 receptor binding assays
- GIP receptor signaling
- Glucagon receptor kinetics
- Incretin pathway cross-talk
- Hepatic lipid-pathway models
Investigational / Restricted Reference Notice: This compound corresponds to an investigational or prescription-class molecular target in certain jurisdictions. Offered exclusively as an unapproved laboratory reference material for qualified bench research. Not authorized by Health Canada and strictly not for human or veterinary use.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, natural health product, or cosmetic. Not authorized by Health Canada. Certificates of analysis (COAs) are available on request per lot — Testing & COAs or peptides@onyxpeptide.ca.
Availability & pricing
Contact Onyx Peptides to confirm laboratory availability, pricing, or lot COAs. 18+ and research-use confirmation required before WhatsApp inquiry.
Compound Profile
